GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Why investors allow this kind of irresponsible spending is beyond me.<

The blame rests on GTC’s insular BoD, IMHO.

Although the BoD has become somewhat less insular over time, it still includes four directors who have served since the early 1990’s and are unlikely to question the path charted by management. These four directors plus Cox and Béchon constitute a majority of the eleven-member board (#msg-28839475).